These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37788946)

  • 1. A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia.
    Cheuk NKW; Tse W; Tsui HKH; Ma CF; Chun JSW; Chung AKK; Chan SKW
    Schizophr Res; 2024 Jun; 268():205-222. PubMed ID: 37788946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the effects of treatment resistance and anticholinergic burden on cognitive function domains in patients with schizophrenia.
    Chan SKW; Pang TSW; Tsui HKH; Suen YN; Yan WC; Tsui CF; Poon LT; Chan CWH; Lo A; Cheung KM; Hui CLM; Chang WC; Lee EHM; Chen EYH; Honer WG
    Psychiatry Res; 2024 Jul; 337():115985. PubMed ID: 38820652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
    Masuda T; Misawa F; Takase M; Kane JM; Correll CU
    JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBTp for people with treatment refractory schizophrenia on clozapine: a systematic review and meta-analysis.
    Todorovic A; Lal S; Dark F; De Monte V; Kisely S; Siskind D
    J Ment Health; 2023 Feb; 32(1):321-328. PubMed ID: 33076721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
    Siskind D; Orr S; Sinha S; Yu O; Brijball B; Warren N; MacCabe JH; Smart SE; Kisely S
    Br J Psychiatry; 2022 Mar; 220(3):115-120. PubMed ID: 35049446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia.
    Dong S; Schneider-Thoma J; Bighelli I; Siafis S; Wang D; Burschinski A; Schestag K; Samara M; Leucht S
    Eur Arch Psychiatry Clin Neurosci; 2024 Jun; 274(4):917-928. PubMed ID: 37526675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials.
    Chang CH; Lin CH; Liu CY; Chen SJ; Lane HY
    J Psychopharmacol; 2020 May; 34(5):495-505. PubMed ID: 32122256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia.
    Lee MA; Cola P; Jayathilake K; Meltzer HY
    J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):211-219. PubMed ID: 36975722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder.
    Llorca-Bofí V; Bioque M; Madero S; Mallorquí A; Oliveira C; Garriga M; Parellada E; García-Rizo C
    Pharmacopsychiatry; 2024 Jul; 57(4):173-179. PubMed ID: 38621701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study.
    Tien Y; Wang XY; Huang SC; Huang HP
    J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38696112
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis.
    Bartoli F; Crocamo C; Di Brita C; Esposito G; Tabacchi TI; Verrengia E; Clerici M; Carrà G
    J Psychiatr Res; 2019 Jan; 108():24-33. PubMed ID: 30447508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
    Zhu MH; Liu ZJ; Hu QY; Yang JY; Jin Y; Zhu N; Huang Y; Shi DH; Liu MJ; Tan HY; Zhao L; Lv QY; Yi ZH; Wu FC; Li ZZ
    Mil Med Res; 2022 Oct; 9(1):59. PubMed ID: 36253804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials.
    Siafis S; Schneider-Thoma J; Hamza T; Bighelli I; Dong S; Hansen WP; Davis JM; Salanti G; Leucht S
    BMJ Open; 2023 Feb; 13(2):e064504. PubMed ID: 36810167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis.
    Tiihonen J; Wahlbeck K; Kiviniemi V
    Schizophr Res; 2009 Apr; 109(1-3):10-4. PubMed ID: 19186030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic and clinical variables associated with response to clozapine in schizophrenia: a systematic review and meta-analysis.
    Griffiths K; Millgate E; Egerton A; MacCabe JH
    Psychol Med; 2021 Feb; 51(3):376-386. PubMed ID: 33602358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials.
    Wang G; Zheng W; Li XB; Wang SB; Cai DB; Yang XH; Ungvari GS; Xiang YT; Correll CU
    J Psychiatr Res; 2018 Oct; 105():23-32. PubMed ID: 30144667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses.
    Souza JS; Kayo M; Tassell I; Martins CB; Elkis H
    CNS Spectr; 2013 Apr; 18(2):82-9. PubMed ID: 23253621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.